Champions Oncology, Inc. (CSBR) has seen some recent volatility in the market and its shares closed trading at $7.27 yesterday. People are starting to take interest of CSBR as the shares traded as high as $7.90 and as low as $7.26 in the previous trading day.

Champions Oncology, Inc. (CSBR) average trading volume is 47.77K. However, in the previous trading day Champions Oncology, Inc. (CSBR) exchanged 18,970 shares. The First downside support level on CSBR is $6.81 and the First upside resistance level on CSBR is $10.20. CSBR 50-day moving average is $8.88 and CSBR 200-day moving average is $8.19.

Champions Oncology, Inc. (CSBR) recent performance has been indicated by the recent movement in CSBR shares. CSBR has performed -18.86% over the past 4 weeks, CSBR has performed -21.74% over the past quarter and CSBR has shown 21.17% over the past 1 year. Champions Oncology, Inc. (CSBR) has a 1 year range of $4.02 to $10.89. Champions Oncology, Inc. (CSBR) is trading 80.85% from its 1 year low and -33.24% from its 1 year high. Champions Oncology, Inc. (CSBR) is showing a 1.41% short float showing the quantity short in the float.

CSBR has 12.42M shares outstanding and 9.97M shares in the float. Champions Oncology, Inc. (CSBR) currently has a market cap of $92.77M and income of -2.00M. The EPS next quarter for CSBR is 0.02 and projected EPS next year is 180.72%. The market cap of Champions Oncology, Inc. (CSBR) at $92.77M signifies how many People own shares of CSBR and is calculated off the last price ($7.27) of CSBR and the quantity of shares outstanding (12.42M) with Champions Oncology, Inc. (CSBR).

Champions Oncology, Inc. (CSBR) has aggregate cash (mrq) of 8.34M, aggregate cash per share (mrq) of 0.65, aggregate debt of CSBR is at 3.8M and aggregate debt/equity (mrq) is 71.42. . Champions Oncology, Inc. (CSBR) operational cash flow (ttm) is 2.9M, CSBR leveraged free cash flow (ttm) is 1.27M.

CSBR is trading -17.60% below (bearish) its SMA20, -19.97% below (bearish) its SMA50 and -8.58% below (bearish) its SMA200.